Across TCGA pan-cancer cohorts, DOC2B Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated DOC2B data layer compared with 24 for mass-spec protein and 1 for mass-spec protein.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher DOC2B Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated DOC2B expression acts as an unfavorable survival marker.
UCEC are the cancer types where DOC2B Mutation most reproducibly stratifies survival.